Plaintiffs suing the Big Three tuna companies—Bumble Bee Foods, StarKist, and Chicken of the Sea—over alleged price fixing among the competitors have been granted class certification.
The judge’s decision is good news for the plaintiffs, as such certification generally means lower legal costs and an increase in the likelihood of seeing a financial reward.
The lawsuits allege that the three largest tuna companies conspired to keep the price of the staple of lunch boxes and pantries artificially high between at least November 2010 and December 2016.
Federal Judge Janis Sammartino last week approved three tracks for the suits to continue. One class is the “direct purchaser plaintiffs,” which includes warehouse and distribution companies like Olean Wholesale Grocery, Piggly Wiggly, and Benjamin Foods.
The second is the “commercial food preparer plaintiffs,” which includes eateries like Thyme Cafe & Market, A-1 Diner, and Groucho’s Deli of Five Points.
The third track is the “end payer plaintiff,” which represents individual consumers who bought tuna to eat. The class includes consumers in 30 states, Washington, DC, and Guam.
The 59-page order was filed July 30 in the US District Court for the Southern District of California.
Full Content: Post Gazette
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas